| |
|
|
|
Cancer Genetics Inc.  
|
|
0.1787 0.004 (0.02%) |
05-24 09:43 |
|
Open: |
0.18 |
Pre close: |
0.1745 |
Target:
|
0.28
|
|
High: |
0.183 |
Low: |
0.1705 |
Resistance:
|
0.24
0.30
|
|
Volume: |
131,570 |
Market Cap: |
10M |
Support:
|
0.15
0.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.19
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.22 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.26 |
Stochastic Oscillator |
%K(14,3):
|
20.98  |
|
MA(250): |
0.59 |
%D(3): |
16.08 |
|
Average Volume(K) |
3-Month: |
159056
|
52-Week |
High:
|
1.30 |
|
10-Days: |
161588 |
Low: |
0.15 |
|
RSI |
RSI(14):
|
31.36 |
Change(%): |
-82.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-125.7 |
Shares Out. (M) |
56.28 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-47.7 |
Shares Float (M) |
50.43 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
-0.02 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-9.3 |
% Held by Institutions |
5.40 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.730 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.10 |
|
Profit Margin |
-79.81 |
Operating Cash Flow
(M) |
-12.55 |
P/S |
9723624.00 |
|
Operating Margin |
-66.23 |
Levered Free Cash Flow
(M) |
0.75 |
P/CF |
-0.78 |
|
|
|
|
|
|
